Internal Bra Complications: Injuries Linked to Defective Breast Mesh [2026 Guide]

An “internal bra” in breast surgery is a technique where a surgeon adds internal support to help stabilize the lower portion of the breast or the implant pocket using a mesh or scaffold.

Plastic surgery organizations describe it as a soft-tissue scaffold intended to resist downward stretch and help hold shape during healing.

In implant based breast reconstruction, surgeons may use a mesh-like material to help cover or support the implant’s lower pole, a concept that has been described in the medical literature as creating an “internal bra.”

The same general approach is also used in cosmetic breast surgery, including lifts and augmentation-lift combinations, and sometimes in other breast surgeries such as reductions when surgeons believe added reinforcement is needed.

The intended goal is support and shape control during healing, but outcomes can differ based on patient factors, technique, and how the body responds to an implanted material.

Importantly, the FDA has stated that the safety and effectiveness of surgical mesh in breast surgery has not been determined by the FDA and that no surgical mesh products are cleared or approved specifically for breast surgery such as augmentation or reconstruction.

For patients, this means the use of mesh in breast procedures can involve added considerations around informed consent, complication risk, and the possibility of additional treatment if recovery does not follow the expected course.

Internal Bra Techniques Explained

Internal bra procedures are used across a range of breast surgeries when surgeons believe added internal support may help control shape, position, or healing.

In reconstructive surgery, internal support is often added after mastectomy to help stabilize an implant against the chest wall and define the breast pocket during recovery.

Similar techniques may be used in cosmetic procedures, including breast reduction or lift surgeries, when tissue quality is thin or stretched and long-term support is a concern.

Surgeons may select different approaches depending on anatomy, implant size, and the desired aesthetic outcomes.

While the goals vary, all internal bra techniques involve placing material inside the body to influence how the breast heals and holds shape over time.

Common internal bra techniques include:

• Securing mesh or scaffold material to the chest wall to reinforce the lower pole of the breast
• Creating an internal sling beneath the breast pocket to support an implant or reposition tissue
• Reinforcing weakened or stretched tissue during revision or reconstructive surgery
• Supporting the breast pocket to limit downward movement or implant displacement
• Adding internal reinforcement during breast reduction or lift procedures when tissue support is limited

Types of Materials Used for Internal Support

Internal bra support can be created using several different types of surgical mesh materials, each with distinct properties and risk profiles.

Some products are designed to remain in the body long term, while others are intended to gradually absorb as healing progresses and the surrounding tissue provides support.

The choice between biologic and synthetic meshes often depends on surgeon preference, patient anatomy, and the specific goals of the procedure.

Regardless of material, any type of surgical mesh introduces foreign material into the body, which can affect healing and inflammatory response.

Differences in mesh materials and mesh brands are one reason outcomes and complication rates can vary from patient to patient.

Common types of materials used for internal support include:

• Synthetic mesh, typically made from polymer-based materials designed to provide structural reinforcement
• Acellular dermal matrix (ADM), derived from processed human or animal tissue with cells removed
• Biologic meshes, which use donated tissue to act as a scaffold for tissue integration
• Biosynthetic meshes, which combine synthetic structure with absorbable properties
• Permanent mesh materials, intended to remain in place long term
• Resorbable scaffolds, designed to degrade over time as the surrounding tissue heals

Internal bra procedures add an extra layer of complexity to breast surgery because they introduce internal mesh or scaffold material into tissue that is already healing from an implant, lift, reduction, or reconstruction.

Plastic surgeons may use internal mesh to support breast shape and implant positioning, but outcomes can vary based on anatomy, surgical technique, and the body’s response to foreign material.

Some patients heal without major issues, while others develop complications that extend beyond routine post-operative recovery.

Common complications of internal bra procedures include infection, chronic pain, mesh migration/extrusion, seroma, hematoma, and tissue necrosis.

These problems can involve the incision, the implant pocket, or the surrounding soft tissue, and they sometimes require additional procedures to correct.

In the broader medical literature and patient reports, adverse events following mesh-supported breast surgery often fall into patterns that include infection, fluid buildup, wound complications, scarring, and implant positioning problems.

When complications occur, they can affect comfort, symmetry, and long-term breast shape, even after the initial recovery period ends.

Because internal mesh is placed within the body, symptoms may develop soon after surgery or emerge later as scar tissue forms and the breast changes over time.

The sections below break down the most commonly reported adverse events and explain how these complications are described in clinical practice.

Early Post-Surgical Complications

Many women have reported severe side effects such as chronic swelling, tissue hardening, infection, and implant failure after internal bra mesh implantation.

Complications can arise shortly after surgery when healing does not progress as anticipated or when the body reacts to implanted material.

In the early post-operative period, symptoms may worsen instead of improve, or new problems may emerge that require medical attention.

The most commonly reported complications post-surgery include:

• Surgical site infection
• Seroma or fluid buildup around the implant or mesh
• Hematoma or internal bleeding
• Delayed wound healing or incision separation
• Early wound breakdown or skin compromise

Skin erosion and tissue necrosis can occur as a result of chronic inflammation, infection, or mechanical irritation around internal bra mesh implants, leading to urgent care needs.

Skin erosion may occur if the mesh is placed too close to the skin or affects blood supply, potentially exposing the mesh.

Infection and abscess formation are complications that can occur when bacteria attach to the surface of the implant and form resistant biofilms, often leading to removal of both the mesh and the implant.

Women have reported seromas, where fluid collects around the implant due to irritation from mesh movement or breakdown, often requiring multiple drainings or corrective surgeries.

Structural and Implant-Related Complications

Internal support techniques are often used to help maintain implant position and breast shape, but structural problems can still develop as healing progresses.

These issues may occur when the implant pocket changes, scar tissue tightens, or the internal support does not provide the intended reinforcement.

Some complications affect the appearance of the breast, while others cause pain and require revision surgery to correct implant position.

In more serious cases, the implanted material can become exposed or fail to remain covered by healthy tissue.

Common structural and implant-related complications include:

• Implant malposition, including bottoming out, lateral drift, or implant displacement
• Breast asymmetry or visible contour changes that develop during healing
• Capsular contracture causing firmness, distortion, and pain
• Loss of support or stretching of the implant pocket over time
• Mesh extrusion or implant exposure through the incision or overlying skin
• Need for revision surgery, implant exchange, or implant removal

When these complications occur, surgeons often evaluate implant position, tissue quality, and whether scar tissue or pocket changes are driving the problem. Treatment can range from monitoring and supportive care to operative correction, depending on severity. Because structural complications can evolve gradually, symptoms and visible changes may appear weeks or months after the initial procedure rather than immediately.

Tissue and Nerve-Related Injuries

Breast surgery that involves internal support materials can affect the surrounding soft tissue and nearby nerves as healing progresses.

When inflammation, scarring, or pressure develops, tissue and nerve-related injuries may cause symptoms that extend beyond routine post-operative discomfort.

These injuries can interfere with sensation, comfort, and long-term healing, and they may persist even after other complications have resolved.

In some cases, additional treatment or surgery is required to address ongoing symptoms.

Common tissue and nerve-related injuries include:

• Tissue damage or thinning of the overlying skin
• Tissue death, including areas of skin necrosis
• Chronic pain or persistent tenderness at the surgical site
• Nerve irritation or nerve injury causing numbness, tingling, or burning sensations
• Pain related to scar tissue formation or tightening around the implant
• Sensitivity changes affecting the breast, chest wall, or nipple area

How often internal bra complications occur varies widely by procedure type, patient factors, and the specific material used, which is why published rates can look very different from one study to the next.

The US Food and Drug Administration has stated that the safety and effectiveness of surgical mesh in breast surgery has not been determined by the agency, and it encourages health care providers to report adverse events associated with mesh use through MedWatch.

In a 2021 FDA safety communication emphasizing differences among acellular dermal matrix products, the agency described a higher chance of complications with certain ADMs in implant-based reconstruction.

That FDA communication and related analyses focus on a significant difference in complication risk across materials and brands rather than treating “mesh” as one uniform category.

The FDA’s late-2023 provider letter on labeling updates also highlights that increased mesh use in breast surgery is occurring despite this uncertainty, which affects how clinicians and patients interpret complication data.

Overall, the most defensible way to discuss “how often” internal bra complications occur is to cite published pooled estimates where available, then explain that real-world risk can move meaningfully based on the mesh type, surgical plane, mastectomy flap quality, and post-operative course.

Reported Complication Rates in Published Studies

Published complication rates for mesh-supported “internal bra” style breast procedures vary because studies often mix different patient populations, different surgical techniques, and different mesh categories, including synthetic meshes, biosynthetic scaffolds, and acellular dermal matrices (ADMs).

FDA materials also caution against treating “mesh” as one uniform product category, and the agency has specifically warned that ADM products used in implant-based breast reconstruction can show differing complication rates by brand.

In implant-based reconstruction using biosynthetic mesh, a 2025 meta-analysis in Aesthetic Surgery Journal pooled outcomes across 24 studies (2,167 breasts) and reported seroma 5.26%, hematoma 2.5%, skin necrosis 5.5%, infection 4.8%, and implant loss 3.85%.

A 2024 systematic review and meta-analysis in Aesthetic Surgery Journal Open Forum reported meta-rates (noncomparative studies) of seroma 3%, infection 4%, reoperation 10%, and explant 3% in alloplastic (implant-based) reconstruction using synthetic mesh, and it also reported that comparative studies showed a reduced risk of reoperation and explant for synthetic mesh versus biologic mesh in the included comparisons.

In aesthetic (cosmetic) breast surgery, a 2025 narrative systematic review (31 studies, 2,425 patients) reported generally low complication rates such as seroma, hematoma, and infection, but concluded the evidence base is not strong enough to recommend routine mesh use because many studies are retrospective and outcomes are not standardized.

Taken together, these publications support two cautious points for a patient-facing guide: complication rates are measurable and non-trivial, and the numbers are not interchangeable across mesh types, indications, or surgical settings.

Examples of reported rates in the literature (study-dependent):

• Biosynthetic mesh in implant-based reconstruction (pooled): seroma 5.26%, hematoma 2.5%, skin necrosis 5.5%, infection 4.8%, implant loss 3.85%
• Synthetic mesh in implant-based reconstruction (meta-rates): seroma 3%, infection 4%, reoperation 10%, explant 3%
• Aesthetic breast surgery literature: complications often reported as “low” (seroma/hematoma/infection), but authors note evidence limitations and do not endorse routine use
• ADM risk variability: FDA warns about differing complication outcomes, stating that some ADM brands used in implant-based reconstruction showed a higher chance of complications or problems compared to others in FDA-reviewed data

Why Reported Rates Vary

Reported complication rates vary because internal bra procedures are not a single, standardized surgery and involve different techniques, materials, and patient populations.

Studies may combine cosmetic and reconstructive cases, primary surgeries and revisions, or different mesh types, which can significantly affect outcomes.

Follow-up periods also differ, with some studies reporting only early complications while others track patients for years, capturing later problems such as capsular contracture or implant loss.

Surgeon experience, mastectomy flap quality, implant size, and patient health factors such as smoking or prior radiation can all influence complication risk.

The type of mesh used matters as well, because biologic, biosynthetic, and synthetic materials interact with tissue in different ways and have distinct complication profiles.

Because of these variables, published rates should be read as general reference points rather than precise predictions for any individual patient.

Long-term effects matter in internal bra cases because complications are not always limited to the first weeks after surgery.

Soft tissue reinforcement with mesh or scaffolds is intended to provide added support during healing, but some patients report problems that continue after the initial recovery period ends.

In alloplastic breast reconstruction, late complications may appear as scar tissue evolves, the implant pocket changes, or the breast settles into a new shape over time.

Adverse biologic or synthetic mesh outcomes can include persistent pain, repeated infections, structural failure of support, or progressive tightening and distortion that develops months later.

When complications persist, treatment can shift from routine follow-up to staged revision planning, including implant exchange or removal in more serious cases.

Patients may also face lasting changes in appearance, sensation, and comfort that affect daily life long after surgery.

The sections below explain the most common long-term outcomes reported in mesh-supported breast procedures and why they can require extended medical care.

Chronic Pain and Ongoing Symptoms

Some patients report pain that does not resolve after the expected post-surgical recovery window, even when the incision appears healed.

Chronic pain may feel deep, burning, sharp, or pressure-like, and it can worsen with movement, touch, or changes in implant position.

Ongoing symptoms are often evaluated alongside scar tissue development, inflammation around foreign material, and any signs of implant pocket changes.

When pain persists, patients may require prolonged medication, physical therapy, imaging, or additional procedures to determine the cause.

Common chronic pain and ongoing symptoms include:

• Persistent tenderness or pain that limits normal activity
• Burning, tingling, numbness, or hypersensitivity consistent with nerve irritation
• Tightness or pressure sensations that worsen over time
• Ongoing swelling or recurrent fluid collections
• Pain with arm movement, exercise, or sleeping positions
• Discomfort related to scar tissue thickening or implant firmness

Repeat Surgeries and Reconstruction Changes

When complications persist after an internal bra procedure, treatment often shifts from observation to surgical correction.

Women have reported chronic inflammation and painful hardening around the implant site, which can make the breast feel firm, distorted, or difficult to tolerate and may require revision surgery.

In more severe cases, surgeons may need to remove or replace an implant, revise the implant pocket, or address wound problems that do not heal with conservative care.

Skin erosion and tissue necrosis can occur as a result of chronic inflammation, infection, or mechanical irritation around internal bra mesh implants, sometimes creating urgent care needs.

Each additional surgery can change the reconstruction plan, increase scarring, and affect long-term results.

Reasons additional surgeries may be required include:

• Persistent infection that does not resolve with antibiotics or drainage
• Chronic inflammation and painful hardening around the implant site
• Implant malposition, bottoming out, or recurrent breast asymmetry
• Wound breakdown, skin erosion, or implant/mesh exposure
• Tissue necrosis requiring debridement or staged reconstruction
• Recurrent seroma or chronic fluid buildup
• Capsular contracture causing pain, firmness, and distortion
• Implant removal or exchange due to ongoing symptoms or reconstruction failure

Scarring, Asymmetry, and Aesthetic Impact

When complications occur, scarring can become thicker and more irregular than expected, and it may tighten the breast pocket or pull the breast into an unnatural shape.

Asymmetry can develop if one side heals differently, if an implant shifts, or if revision surgery changes the pocket or soft tissue support.

Even without implant loss, subtle contour changes can become visible over time, including rippling, flattening, or a lower pole that no longer holds its intended position.

Tissue damage, skin breakdown, or necrosis can leave permanent textural changes and scar patterns that are difficult to correct.

For some patients, the aesthetic impact is paired with discomfort, making it harder to find a stable result without additional surgery.

These outcomes are often documented in follow-up notes and photographs because they affect both appearance and long-term function.

Eligibility for an internal bra mesh claim review usually depends on whether a mesh or scaffold was used in your breast procedure and whether you experienced complications that required medical treatment beyond routine recovery.

Many reviews begin with documentation, including operative reports, implant logs, and device identifiers that confirm the product and the timing of implantation.

Complications that often prompt review include infection, chronic fluid buildup, wound breakdown, mesh exposure, implant malposition, chronic pain, capsular contracture, or the need for revision or removal surgery.

The question is not only whether a complication occurred, but whether the medical record supports a clear timeline showing how the problem developed and what interventions were required.

Some patients may still have a viable claim even if symptoms appeared months or years later, depending on the state’s statute of limitations and discovery rules.

Because internal bra devices entered clinical practice through different pathways and were used across multiple procedures, claim evaluation also considers the informed-consent record and what information was provided about risks at the time of surgery.

Public discussion of internal bra products has also increased, including legal and regulatory scrutiny of how these materials were used and how risks were communicated, but each case still turns on individualized proof.

A licensed attorney can review your records and explain whether your circumstances meet the basic criteria for an internal bra mesh claim review.

Gathering Evidence for an Internal Bra Mesh Claim

Strong evidence matters in internal bra mesh claims because it confirms exactly which product was implanted and documents how complications developed over time.

Operative reports, implant logs, and follow-up records create the medical timeline needed to evaluate whether the injuries and treatment course support a claim.

The most useful evidence is objective, date-stamped documentation that connects the procedure to the complications and the resulting costs and losses.

Evidence to collect includes:

• Operative report and surgeon notes from the original procedure
• Implant log and device sticker sheet showing the mesh name, UDI, and lot/catalog numbers
• Hospital discharge records and post-op follow-up notes documenting symptoms and complications
• Wound care records, photos (if available), and notes describing breakdown, erosion, or exposure
• Imaging reports (ultrasound, MRI, CT) used to evaluate fluid, infection, or implant position
• Lab results and culture reports if infection was suspected or confirmed
• Records from any revision surgery, washout procedures, implant exchange, or implant removal
• Pathology or explant documentation if mesh was removed, plus preservation records if retained
• Itemized medical bills and insurance statements related to treatment and additional surgeries
• Employment records showing missed work or reduced earning capacity
• A written timeline of symptoms, appointments, and major treatment events to match the chart

Potential Damages in Internal Bra Mesh Claims

Damages are the losses a person claims after an injury, including both financial costs and the personal impact of the complications.

Lawyers assess damages by reviewing medical records, billing, employment documentation, and the treatment timeline to quantify what the complications cost and how they affected day-to-day life.

The goal is to present a clear, evidence-based calculation that reflects the severity of the injuries and the long-term consequences.

Damages may include:

• Past medical expenses (hospital care, antibiotics, imaging, wound treatment)
• Future medical care (revision surgery, implant exchange, implant removal, follow-up care)
• Lost wages and reduced earning capacity
• Physical pain and ongoing symptoms, including chronic pain
• Emotional distress related to complications and body changes
• Scarring, tissue loss, and permanent disfigurement
• Out-of-pocket costs (prescriptions, supplies, travel, caregiving)
• Loss of enjoyment of life and reduced ability to participate in normal activities

Internal bra complication claims often depend on careful review of surgical records, product identification, and the full course of medical treatment following surgery.

When recovery involves persistent pain, infection, implant failure, or repeat surgeries, the details matter, including what material was used and how complications developed over time.

TorHoerman Law reviews internal bra complication claims by focusing on documentation, medical timelines, and the real impact these injuries have had on a person’s health and quality of life.

If you believe internal bra mesh played a role in serious complications after your breast surgery, TorHoerman Law can evaluate your records and explain whether your situation may qualify for further review.

Contact TorHoerman Law to request a confidential case review and learn what next steps may be available.